{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:48:11Z","timestamp":1754484491657,"version":"3.41.2"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1212\/con.0000000000000273","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T10:23:55Z","timestamp":1454667835000},"page":"246-261","source":"Crossref","is-referenced-by-count":3,"title":["Special Issues in Epilepsy"],"prefix":"10.1212","volume":"22","author":[{"given":"Chad","family":"Carlson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher T.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_3_2","unstructured":"US Census Bureau. The next four decades: the older population in the United States: 2010 to 2050: population estimates and projections. www.census.gov\/prod\/2010pubs\/p25-1138.pdf. Issued May 2010. Accessed December 3 2015."},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","unstructured":"Hauser WA Annegers JF Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester Minnesota: 1935\u20131984. Epilepsia 1993; 34(3): 453\u2013468. doi:10.1111\/j.1528-1157.1993.tb02586.x.","DOI":"10.1111\/j.1528-1157.1993.tb02586.x"},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","unstructured":"Olafsson E Ludvigsson P Gudmundsson G et al. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol 2005; 4(10): 627\u2013634. doi:10.1016\/S1474-4422(05)70172-1.","DOI":"10.1016\/S1474-4422(05)70172-1"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","unstructured":"Sillanp\u00e4\u00e4 M K\u00e4lvi\u00e4inen R Klaukka T et al. Temporal changes in the incidence of epilepsy in Finland: nationwide study. Epilepsy Res 2006; 71(2\u20133): 206\u2013215. doi:10.1016\/j.eplepsyres.2006.06.017.","DOI":"10.1016\/j.eplepsyres.2006.06.017"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","unstructured":"Lhatoo SD Johnson AL Goodridge DM et al. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term prospective population-based cohort. Ann Neurol 2001; 49(3): 336\u2013344. doi:10.1002\/ana.70.","DOI":"10.1002\/ana.70.abs"},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","unstructured":"Ramsay RE Rowan AJ Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology 2004; 62(5 suppl 2): S24\u2013S29. doi:10.1212\/WNL.62.5_suppl_2.S24.","DOI":"10.1212\/WNL.62.5_suppl_2.S24"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","unstructured":"Abubakr A Wambacq I. Seizures in the elderly: video\/EEG monitoring analysis. Epilepsy Behav 2005; 7(3): 447\u2013450. doi:10.1016\/j.yebeh.2005.06.012.","DOI":"10.1016\/j.yebeh.2005.06.012"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","unstructured":"McBride AE Shih TT Hirsch LJ. Video-EEG monitoring in the elderly: a review of 94 patients. Epilepsia 2002; 43(2): 165\u2013169. doi:10.1046\/j.1528-1157.2002.24401.x.","DOI":"10.1046\/j.1528-1157.2002.24401.x"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","unstructured":"Kellinghaus C Loddenkemper T Dinner DS et al. Seizure semiology in the elderly: a video analysis. Epilepsia 2004; 45(3): 263\u2013267. doi:10.1111\/j.0013-9580.2004.29003.x.","DOI":"10.1111\/j.0013-9580.2004.29003.x"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","unstructured":"Annegers JF Hauser WA Lee JR Rocca WA. Incidence of acute symptomatic seizures in Rochester Minnesota 1935\u20131984. Epilepsia 1995; 36(4): 327\u2013333. doi:10.1111\/j.1528-1157.1995.tb01005.x.","DOI":"10.1111\/j.1528-1157.1995.tb01005.x"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","unstructured":"DeLorenzo RJ Hauser WA Towne AR et al. A prospective population-based epidemiologic study of status epilepticus in Richmond Virginia. Neurology 1996; 46(4): 1029\u20131035. doi:10.1212\/WNL.46.4.1029.","DOI":"10.1212\/WNL.46.4.1029"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","unstructured":"Towne AR Pellock JM Ko D DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994; 35(1): 27\u201334. doi:10.1111\/j.1528-1157.1994.tb02908.x.","DOI":"10.1111\/j.1528-1157.1994.tb02908.x"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","unstructured":"Treiman DM Walker MC. Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus. Epilepsy Res 2006; 68(suppl 1): S77\u2013S82. doi:10.1016\/j.eplepsyres.2005.07.020.","DOI":"10.1016\/j.eplepsyres.2005.07.020"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","unstructured":"Kellinghaus C St\u00f6gbauer F. Treatment of status epilepticus in a large community hospital. Epilepsy Behav 2012; 23(3): 235\u2013240. doi:10.1016\/j.yebeh.2011.12.020.","DOI":"10.1016\/j.yebeh.2011.12.020"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","unstructured":"Misra UK Kalita J Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 2006; 67(2): 340\u2013342. doi:10.1212\/01.wnl.0000224880.35053.26.","DOI":"10.1212\/01.wnl.0000224880.35053.26"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","unstructured":"Garrard J Harms S Hardie N et al. Antiepileptic drug use in nursing home admissions. Ann Neurol 2003; 54(1): 75\u201385. doi:10.1002\/ana.10593.","DOI":"10.1002\/ana.10593"},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","unstructured":"Italiano D Perucca E. Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update. Clin Pharmacokinet 2013; 52(8): 627\u2013645. doi:10.1007\/s40262-013-0067-4.","DOI":"10.1007\/s40262-013-0067-4"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","unstructured":"Malow BA Levy K Maturen K Bowes R. Obstructive sleep apnea is common in medically refractory epilepsy patients. Neurology 2000; 55(7): 1002\u20131007. doi:10.1212\/WNL.55.7.1002.","DOI":"10.1212\/WNL.55.7.1002"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","unstructured":"Pornsriniyom D Shinlapawittayatorn K Fong J et al. Continuous positive airway pressure therapy for obstructive sleep apnea reduces interictal epileptiform discharges in adults with epilepsy. Epilepsy Behav 2014; 37: 171\u2013174. doi:10.1016\/j.yebeh.2014.06.025.","DOI":"10.1016\/j.yebeh.2014.06.025"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","unstructured":"Brodie MJ Overstall PW Giorgi L. Multicentre double-blind randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 1999; 37(1): 81\u201387. doi:10.1016\/S0920-1211(99)00039-X.","DOI":"10.1016\/S0920-1211(99)00039-X"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","unstructured":"Saetre E Perucca E Isoj\u00e4rvi J et al. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007; 48(7): 1292\u20131302. doi:10.1111\/j.1528-1167.2007.01128.x.","DOI":"10.1111\/j.1528-1167.2007.01128.x"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","unstructured":"Rowan AJ Ramsay RE Collins JF et al. New onset geriatric epilepsy: a randomized study of gabapentin lamotrigine and carbamazepine. Neurology 2005; 64(11): 1868\u20131873. doi:10.1212\/01.WNL.0000167384.68207.3E.","DOI":"10.1212\/01.WNL.0000167384.68207.3E"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","unstructured":"Kutluay E McCague K D\u2019Souza J Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav 2003; 4(2): 175\u2013180. doi:10.1016\/S1525-5050(03)00037-4.","DOI":"10.1016\/S1525-5050(03)00037-4"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","unstructured":"Werhahn KJ Klimpe S Balkaya S et al. The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study. Seizure 2011; 20(4): 305\u2013311. doi:10.1016\/j.seizure.2010.12.015.","DOI":"10.1016\/j.seizure.2010.12.015"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","unstructured":"Trinka E Giorgi L Patten A Segieth J. Safety and tolerability of zonisamide in elderly patients with epilepsy. Acta Neurol Scand 2013; 128(6): 422\u2013428. doi:10.1111\/ane.12162.","DOI":"10.1111\/ane.12162"},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","unstructured":"Bialek F Rydenhag B Flink R Malmgren K. Outcomes after resective epilepsy surgery in patients over 50 years of age in Sweden 1990\u20132009\u2014a prospective longitudinal study. Seizure 2014; 23(8): 641\u2013645. doi:10.1016\/j.seizure.2014.05.003.","DOI":"10.1016\/j.seizure.2014.05.003"},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","unstructured":"Elliott RE Morsi A Kalhorn SP et al. Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response. Epilepsy Behav 2011; 20(1): 57\u201363. doi:10.1016\/j.yebeh.2010.10.017.","DOI":"10.1016\/j.yebeh.2010.10.017"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","unstructured":"Birbeck GL French JA Perucca E et al. Evidence-based guideline: antiepileptic drug selection for people with HIV\/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy. Neurology 2012; 78(2): 139\u2013145. doi:10.1212\/WNL.0b013e31823efcf8.","DOI":"10.1212\/WNL.0b013e31823efcf8"},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","unstructured":"Satishchandra P Sinha S. Seizures in HIV-seropositive individuals: NIMHANS experience and review. Epilepsia 2008; 49(suppl 6): 33\u201341. doi:10.1111\/j.1528-1167.2008.01754.x.","DOI":"10.1111\/j.1528-1167.2008.01754.x"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","unstructured":"Romanelli F Jennings HR Nath A et al. Therapeutic dilemma: the use of anticonvulsants in HIV-positive individuals. Neurology 2000; 54(7): 1404\u20131407. doi:10.1212\/WNL.54.7.1404.","DOI":"10.1212\/WNL.54.7.1404"},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","unstructured":"So YT Beckstead JH Davis RL. Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Ann Neurol 1986; 20(5): 566\u2013572. doi:10.1002\/ana.410200503.","DOI":"10.1002\/ana.410200503"},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","unstructured":"Holtzman DM Kaku DA So YT. New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases. Am J Med 1989; 87(2): 173\u2013177. doi:10.1016\/S0002-9343(89)80693-X.","DOI":"10.1016\/S0002-9343(89)80693-X"},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","unstructured":"Krikorian SA Rudorf DC. Drug-drug interactions and HIV therapy: what should pharmacists know? J Pharm Prac 2005; 18(4): 278\u2013294. doi:10.1177\/0897190005278504.","DOI":"10.1177\/0897190005278504"},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","unstructured":"Siddiqi O Birbeck GL. Safe treatment of seizures in the setting of HIV\/AIDS. Curr Treat Options Neurol 2013; 15(4): 529\u2013543. doi:10.1007\/s11940-013-0237-6.","DOI":"10.1007\/s11940-013-0237-6"},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","unstructured":"Nolan CP DeAngelis LM. Neurologic complications of chemotherapy and radiation therapy. Continuum (Minneap Minn) 2015; 21(2 Neuro-oncology): 429\u2013451. doi:10.1212\/01.CON.0000464179.81957.51.","DOI":"10.1212\/01.CON.0000464179.81957.51"},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","unstructured":"Singh G Rees JH Sander JW. Seizures and epilepsy in oncological practice: causes course mechanisms and treatment. J Neurol Neurosurg Psychiatry 2007; 78(4): 342\u2013349. doi:10.1136\/jnnp.2006.106211.","DOI":"10.1136\/jnnp.2006.106211"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","unstructured":"Pustavoitau A Bhardwaj A Stevens R. Neurological complications of transplantation. J Intensive Care Med 2011; 26(4): 209\u2013222. doi:10.1177\/0885066610389549.","DOI":"10.1177\/0885066610389549"},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","unstructured":"Portell CA Wenzell CM Advani AS. Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia. Clin Pharmacol 2013; 5(suppl 1): 5\u201311. doi:10.2147\/CPAA.S42689.","DOI":"10.2147\/CPAA.S42689"},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","unstructured":"Patsalos PN Fr\u00f6scher W Pisani F van Rijn CM. The importance of drug interactions in epilepsy therapy. Epilepsia 2002; 43(4): 365\u2013385. doi:10.1046\/j.1528-1157.2002.13001.x.","DOI":"10.1046\/j.1528-1157.2002.13001.x"},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","unstructured":"Vecht CJ Wagner GL Wilms EB. Treating seizures in patients with brain tumors: drug interactions between antiepileptic and chemotherapeutic agents. Semin Oncol 2003; 30(6 suppl 19): 49\u201352. doi:10.1053\/j.seminoncol.2003.11.030.","DOI":"10.1053\/j.seminoncol.2003.11.030"},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","unstructured":"Pruitt AA Graus F Rosenfeld MR. Neurological complications of solid organ transplantation. Neurohospitalist 2013; 3(3): 152\u2013166. doi:10.1177\/1941874412466090.","DOI":"10.1177\/1941874412466090"},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","unstructured":"Datar S Singh T Rabinstein AA et al. Long-term risk of seizures and epilepsy in patients with posterior reversible encephalopathy syndrome. Epilepsia 2015; 56(4): 564\u2013568. doi:10.1111\/epi.12933.","DOI":"10.1111\/epi.12933"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","unstructured":"Shepard PW St Louis EK. Seizure treatment in transplant patients. Curr Treat Options Neurol 2012; 14(4): 332\u2013347. doi:10.1007\/s11940-012-0180-y.","DOI":"10.1007\/s11940-012-0180-y"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","unstructured":"Beerhorst K van der Kruijs SJ Verschuure P et al. Bone disease during chronic antiepileptic drug therapy: general versus specific risk factors. J Neurol Sci 2013; 331(1\u20132): 19\u201325. doi:10.1016\/j.jns.2013.05.005.","DOI":"10.1016\/j.jns.2013.05.005"},{"key":"e_1_3_1_56_2","doi-asserted-by":"crossref","unstructured":"Phabphal K Geater A Leelawattana R et al. Prevalence and risk factors of low bone mineral density and 25-hydroxyvitamin D status in young healthy epileptic adult patients in a tropical asian country taking antiepileptic drug. Bone 2009; 45(2): 232\u2013237. doi:10.1016\/j.bone.2009.04.235.","DOI":"10.1016\/j.bone.2009.04.235"},{"key":"e_1_3_1_62_2","doi-asserted-by":"crossref","unstructured":"Lazzari AA Dussault PM Thakore-James M et al. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy\u2013antiepileptic drug and osteoporosis prevention trial. Epilepsia 2013; 54(11): 1997\u20132004. doi:10.1111\/epi.12351.","DOI":"10.1111\/epi.12351"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1212\/CON.0000000000000273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:10:51Z","timestamp":1752156651000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000273"}},"subtitle":["The Elderly, the Immunocompromised, and Bone Health"],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.1212\/CON.0000000000000273"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000273","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"type":"print","value":"1080-2371"},{"type":"electronic","value":"1538-6899"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}